StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 8.6
Power Rank trend -> Rising
07/26/2024 16:00:00 EST
Integra LifeSciences Holdings (IART)
Industry: Medical Devices
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, IART has been trading in a range between $31.74 and $28.69 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
IART is trading between resistance at $34.08 about 8% to the upside and support at $29.19 -7% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $41.79, about a 33% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
Integra LifeSciences Holdings $IART entered a Green zone 12 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $46.89, a potential upside of 49.19% from the recent price of 31.43. The stock is trading 46.64% (potential upside) below its 52 week high of $46.09 and 40.56 % (potential downside) above its 52 week low of $22.36 - based on the recent price.
Company Summary
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.
News
| Earnings Preview: Integra LifeSciences (IART) Q2 Earnings Expected to Decline Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Source: Zacks Investment Research Mon, 22 Jul 2024 11:06:47 -0400 Sentiment: Negative |
| Integra's (IART) New Site to Produce Recalled Tissue Products Integra (IART) is set to recommence the manufacturing of PriMatrix and SurgiMend at its new facility in Braintree, MA. Source: Zacks Investment Research Tue, 16 Jul 2024 10:15:44 -0400 Sentiment: Negative |
| Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts The company plans on operationalizing this new state-of-the-art facility in the first half of 2026 The company plans on operationalizing this new state-of-the-art facility in the first half of 2026 Source: GlobeNewsWire Mon, 15 Jul 2024 08:00:00 -0400 Sentiment: Neutral |
| Why Is Integra (IART) Up 26% Since Last Earnings Report? Integra (IART) reported earnings 30 days ago. What's next for the stock? Source: Zacks Investment Research Wed, 05 Jun 2024 12:35:44 -0400 Sentiment: Positive |
| Is The Options Market Predicting A Spike In Integra LifeScience (IART) Stock? Investors need to pay close attention to Integra LifeScience (IART) stock based on the movements in the options market lately. Source: Zacks Investment Research Thu, 30 May 2024 18:40:24 -0400 Sentiment: Neutral |
Technicals 52 Week Hi: 46.09 52 Week Low: 22.36 Beta: 1.11 50 Day MA: 29.559 200 Day MA: 35.7163 Earnings / Revenue Trends Qtr Earnings Growth YOY: -0.601 Qtr Revenue Growth YOY: -0.031 Forward PE: 9.9404 Trailing PE: 61.8235